105 related articles for article (PubMed ID: 38729313)
1. ENDOSCOPIC ULTRASOUND-GUIDED RADIOFREQUENCY ABLATION FOR PANCREATIC ADENOCARCINOMA.
Wray CJ; O'Brien B; Cen P; Rowe JH; Faraoni EY; Bailey JM; Rubin E; Tammisetti VS; Thosani N
Gastrointest Endosc; 2024 May; ():. PubMed ID: 38729313
[TBL] [Abstract][Full Text] [Related]
2. Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) for advanced pancreatic and periampullary adenocarcinoma.
Thosani N; Cen P; Rowe J; Guha S; Bailey-Lundberg JM; Bhakta D; Patil P; Wray CJ
Sci Rep; 2022 Oct; 12(1):16516. PubMed ID: 36192558
[TBL] [Abstract][Full Text] [Related]
3. Technique, safety, and feasibility of EUS-guided radiofrequency ablation in unresectable pancreatic cancer.
Scopelliti F; Pea A; Conigliaro R; Butturini G; Frigerio I; Regi P; Giardino A; Bertani H; Paini M; Pederzoli P; Girelli R
Surg Endosc; 2018 Sep; 32(9):4022-4028. PubMed ID: 29766302
[TBL] [Abstract][Full Text] [Related]
4. Assessing Endoscopic Ultrasound-Guided Radiofrequency Ablation in Unresectable Pancreatic Ductal Adenocarcinoma: A Single-Center Historic Cohort Study.
Robles-Medranda C; Del Valle R; Puga-Tejada M; Arevalo-Mora M; Cunto D; Egas-Izquierdo M; Estrada-Guevara L; Bunces-Orellana O; Moreno-Zambrano D; Alcivar-Vasquez J; Alvarado-Escobar H; Merfea RC; Barreto-Perez J; Rodriguez J; Calle-Loffredo D; Pitanga-Lukashok H; Baquerizo-Burgos J; Tabacelia D
Gastrointest Endosc; 2024 Mar; ():. PubMed ID: 38518978
[TBL] [Abstract][Full Text] [Related]
5. A Review on Endoscopic Ultrasound-Guided Radiofrequency Ablation (EUS-RFA) of Pancreatic Lesions.
Karaisz FG; Elkelany OO; Davies B; Lozanski G; Krishna SG
Diagnostics (Basel); 2023 Feb; 13(3):. PubMed ID: 36766643
[TBL] [Abstract][Full Text] [Related]
6. A Case Report on Longitudinal Collection of Tumour Biopsies for Gene Expression-Based Tumour Microenvironment Analysis from Pancreatic Cancer Patients Treated with Endoscopic Ultrasound Guided Radiofrequency Ablation.
Lawrence PV; Desai K; Wadsworth C; Mangal N; Kocher HM; Habib N; Sadanandam A; Sodergren MH
Curr Oncol; 2022 Sep; 29(10):6754-6763. PubMed ID: 36290808
[TBL] [Abstract][Full Text] [Related]
7. Randomized phase II study of gemcitabine and S-1 combination therapy versus gemcitabine and nanoparticle albumin-bound paclitaxel combination therapy as neoadjuvant chemotherapy for resectable/borderline resectable pancreatic ductal adenocarcinoma (PDAC-GS/GA-rP2, CSGO-HBP-015).
Yamada D; Kobayashi S; Takahashi H; Akita H; Yamada T; Asaoka T; Shimizu J; Takeda Y; Yokoyama S; Tsujie M; Tomokuni A; Tanemura M; Morimoto O; Murakami M; Kim Y; Nakahira S; Hama N; Sugimoto K; Hashimoto K; Doki Y; Eguchi H
Trials; 2021 Aug; 22(1):568. PubMed ID: 34446057
[TBL] [Abstract][Full Text] [Related]
8. Endoscopic Ultrasound-guided Radiofrequency Ablation Versus Surgical Resection for Treatment of Pancreatic Insulinoma.
Crinò SF; Napoleon B; Facciorusso A; Lakhtakia S; Borbath I; Caillol F; Do-Cong Pham K; Rizzatti G; Forti E; Palazzo L; Belle A; Vilmann P; van Laethem JL; Mohamadnejad M; Godat S; Hindryckx P; Benson A; Tacelli M; De Nucci G; Binda C; Kovacevic B; Jacob H; Partelli S; Falconi M; Salvia R; Landoni L; ; Larghi A
Clin Gastroenterol Hepatol; 2023 Oct; 21(11):2834-2843.e2. PubMed ID: 36871765
[TBL] [Abstract][Full Text] [Related]
9. Clinical Efficacy of Neoadjuvant Chemotherapy with Gemcitabine plus S-1 for Resectable Pancreatic Ductal Adenocarcinoma Compared with Upfront Surgery.
Kitano Y; Inoue Y; Takeda T; Oba A; Ono Y; Sato T; Ito H; Ozaka M; Sasaki T; Sasahira N; Baba H; Takahashi Y
Ann Surg Oncol; 2023 Aug; 30(8):5093-5102. PubMed ID: 37140750
[TBL] [Abstract][Full Text] [Related]
10. Endoscopic ultrasound-guided ethanol and radiofrequency ablation of pancreatic insulinomas: a systematic literature review.
El Sayed G; Frim L; Franklin J; McCrudden R; Gordon C; Al-Shamma S; Kiss S; Hegyi P; Erőss B; Hegyi PJ
Therap Adv Gastroenterol; 2021; 14():17562848211042171. PubMed ID: 34819995
[TBL] [Abstract][Full Text] [Related]
11. Endoscopic ultrasound-guided radiofrequency ablation of unresectable pancreatic cancer with low ablation power and multiple applications: a preliminary study of 11 patients.
Wang J; Wang Y; Zhao Y; Wu X; Zhang M; Hou W; Chen Q; Cheng B
Ann Palliat Med; 2021 Feb; 10(2):1842-1850. PubMed ID: 33440967
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic ultrasound-guided radiofrequency ablation of pancreatic tumors.
Patel V; Abdelbaki A; Thosani NC; Krishna SG
Curr Opin Gastroenterol; 2024 Apr; ():. PubMed ID: 38662451
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic ultrasound-guided injectable therapy for pancreatic cancer: A systematic review.
Kaur J; Jaruvongvanich V; Chandrasekhara V
World J Gastroenterol; 2022 Jun; 28(21):2383-2395. PubMed ID: 35800184
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of endoscopic ultrasound-guided radiofrequency ablation for management of pancreatic lesions: a systematic review and meta-analysis.
Fahmawi Y; Mehta A; Abdalhadi H; Merritt L; Mizrahi M
Transl Gastroenterol Hepatol; 2022; 7():30. PubMed ID: 35892058
[TBL] [Abstract][Full Text] [Related]
15. High-grade dysplasia and adenocarcinoma are frequent in side-branch intraductal papillary mucinous neoplasm measuring less than 3 cm on endoscopic ultrasound.
Wong J; Weber J; Centeno BA; Vignesh S; Harris CL; Klapman JB; Hodul P
J Gastrointest Surg; 2013 Jan; 17(1):78-84; discussion p.84-5. PubMed ID: 22948841
[TBL] [Abstract][Full Text] [Related]
16. Ex-vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy.
Rossi G; Petrone MC; Schiavo Lena M; Albarello L; Palumbo D; Testoni SGG; Archibugi L; Tacelli M; Zaccari P; Vanella G; Apadula L; Crippa S; Belfiori G; Reni M; Falconi M; Doglioni C; De Cobelli F; Healey AJ; Capurso G; Arcidiacono PG
DEN Open; 2023 Apr; 3(1):e152. PubMed ID: 35898840
[TBL] [Abstract][Full Text] [Related]
17.
Kongkam P; Tiankanon K; Seo DW; Luangsukrerk T; Sriuranpong V; Nantavithya C; Jantarattana T; Cañones A; Kerr SJ; Tantitanawat K; Angsuwatcharakon P; Ridtitid W; Kullavanijaya P; Rerknimitr R
Endosc Ultrasound; 2023; 12(5):402-408. PubMed ID: 37969163
[TBL] [Abstract][Full Text] [Related]
18. A single-arm, phase II trial of neoadjuvant gemcitabine and S1 in patients with resectable and borderline resectable pancreatic adenocarcinoma: PREP-01 study.
Motoi F; Satoi S; Honda G; Wada K; Shinchi H; Matsumoto I; Sho M; Tsuchida A; Unno M;
J Gastroenterol; 2019 Feb; 54(2):194-203. PubMed ID: 30182219
[TBL] [Abstract][Full Text] [Related]
19. Endoscopic ultrasound-guided radiofrequency ablation: An effective and safe alternative for the treatment of benign insulinoma.
Furnica RM; Deprez P; Maiter D; Vandeleene B; Borbath I
Ann Endocrinol (Paris); 2020 Dec; 81(6):567-571. PubMed ID: 33285105
[TBL] [Abstract][Full Text] [Related]
20. Radiofrequency ablation for the management of pancreatic mass lesions.
Merchant AA; Goebel AM; Willingham FF
Curr Opin Gastroenterol; 2023 Sep; 39(5):448-454. PubMed ID: 37097824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
